KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Taxes (2016 - 2024)

Edwards Lifesciences has reported Current Taxes over the past 15 years, most recently at $1.3 million for Q4 2024.

  • Quarterly results put Current Taxes at $1.3 million for Q4 2024, down 98.39% from a year ago — trailing twelve months through Dec 2024 was $1.3 million (down 98.39% YoY), and the annual figure for FY2024 was $1.3 million, down 98.39%.
  • Current Taxes for Q4 2024 was $1.3 million at Edwards Lifesciences, up from $1.1 million in the prior quarter.
  • Over the last five years, Current Taxes for EW hit a ceiling of $239.3 million in Q1 2020 and a floor of $1.1 million in Q2 2024.
  • Median Current Taxes over the past 5 years was $143.4 million (2022), compared with a mean of $137.9 million.
  • Biggest five-year swings in Current Taxes: dropped 7.75% in 2020 and later crashed 98.65% in 2024.
  • Edwards Lifesciences' Current Taxes stood at $215.3 million in 2020, then dropped by 11.75% to $190.0 million in 2021, then fell by 24.53% to $143.4 million in 2022, then crashed by 43.79% to $80.6 million in 2023, then plummeted by 98.39% to $1.3 million in 2024.
  • The last three reported values for Current Taxes were $1.3 million (Q4 2024), $1.1 million (Q3 2024), and $1.1 million (Q2 2024) per Business Quant data.